FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Sally Blower

Research Profile

Disorders

Concepts & Ideas

Phenomena

Disease Outbreaks

Chemicals & Drugs

Living Beings

Physiology

Viral Drug Resistance

Geographic Areas

Activities & Behaviors

Computer Simulation

Co-author Network

Publications

TOP 3
Brian J Coburn; Sally Blower
A feasibility analysis of implementing interventions for discordant couples in 14 African countries: implications for epidemic control.
Virginie Supervie; Sally Blower
Predicting effect of pre-exposure prophylaxis on HIV epidemics.
Myong-Hyun Go; Sally Blower
What impact will reducing concurrency have on decreasing the incidence of HIV in heterosexual populations?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Sally Blower (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Brian J Coburn; Sally Blower
A feasibility analysis of implementing interventions for discordant couples in 14 African countries: implications for epidemic control.
AIDS (London, England) 2012;26(15):1969-71.
2012: Virginie Supervie; Sally Blower
Predicting effect of pre-exposure prophylaxis on HIV epidemics.
Lancet 2012;379(9835):2423.
2012: Myong-Hyun Go; Sally Blower
What impact will reducing concurrency have on decreasing the incidence of HIV in heterosexual populations?
Sexually transmitted diseases 2012;39(6):414-5.
2012: Bradley G Wagner; Sally Blower
Universal access to HIV treatment versus universal 'test and treat': transmission, drug resistance & treatment costs.
PloS one 2012;7(9):e41212.
2011: Wafaa M El-Sadr; Brian J Coburn; Sally Blower
Modeling the impact on the HIV epidemic of treating discordant couples with antiretrovirals to prevent transmission.
AIDS (London, England) 2011;25(18):2295-9.
2011: Seema Yasmin; David J Gerberry; Sally Blower
Human papillomavirus vaccination programs and human immunodeficiency virus epidemics.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011;53(8):845-6.
2011: Brian J Coburn; David J Gerberry; Sally Blower
Quantification of the role of discordant couples in driving incidence of HIV in sub-Saharan Africa.
The Lancet infectious diseases 2011;11(4):263-4.
2011: Virginie Supervie; Meagan Barrett; Lesogo Busang; James S Kahn; Themba Lebogang Moeti; Godfrey Musuka; Sally Blower
Modeling dynamic interactions between pre-exposure prophylaxis interventions & treatment programs: predicting HIV transmission & resistance.
Scientific reports 2011;1():185.
2011: Sally Blower; Myong-Hyun Go
The importance of including dynamic social networks when modeling epidemics of airborne infections: does increasing complexity increase accuracy?
BMC medicine 2011;9():88.
2010: Virginie Supervie; Yasmin Halima; Sally Blower
Assessing the impact of mass rape on the incidence of HIV in conflict-affected countries.
AIDS (London, England) 2010;24(18):2841-7.
2010: Virginie Supervie; J Gerardo García-Lerma; Walid Heneine; Sally Blower
HIV, transmitted drug resistance, and the paradox of preexposure prophylaxis.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(27):12381-6.
2010: David J Gerberry; Sally Blower
Predicting the level of vaccine-induced cross-immunity necessary to eliminate HIV epidemics composed of multiple subtypes.
AIDS (London, England) 2010;24(10):1604-406.
2010: Brian J Coburn; Sally Blower
A major HIV risk factor for young men who have sex with men is sex with older partners.
Journal of acquired immune deficiency syndromes (1999) 2010;54(2):113-4.
2010: Robert J Smith; Justin T Okano; James S Kahn; Erin N Bodine; Sally Blower
Evolutionary dynamics of complex networks of HIV drug-resistant strains: the case of San Francisco.
Science (New York, N.Y.) 2010;327(5966):697-701.
2010: Raffaele Vardavas; Romulus Breban; Sally Blower
A universal long-term flu vaccine may not prevent severe epidemics.
BMC research notes 2010;3():92.
2009: Bradley G Wagner; Brian J Coburn; Sally Blower
Calculating the potential for within-flight transmission of influenza A (H1N1).
BMC medicine 2009;7():81.
2009: Romulus Breban; Sonia Napravnik; James Kahn; Sally Blower
Quantifying the treatment efficacy of reverse transcriptase inhibitors: new analyses of clinical data based on within-host modeling.
BMC public health 2009;9 Suppl 1():S11.
2009: Brian J Coburn; Bradley G Wagner; Sally Blower
Modeling influenza epidemics and pandemics: insights into the future of swine flu (H1N1).
BMC medicine 2009;7():30.
2008: Romulus Breban; Virginie Supervie; Justin T Okano; Raffaele Vardavas; Sally Blower
Is there any evidence that syphilis epidemics cycle?
The Lancet infectious diseases 2008;8(9):577-81.
2007: Elissa J Schwartz; Erin N Bodine; Sally Blower
Effectiveness and efficiency of imperfect therapeutic HSV-2 vaccines.
Human vaccines 2007;3(6):231-8.
2007: Romulus Breban; Raffaele Vardavas; Sally Blower
Mean-field analysis of an inductive reasoning game: application to influenza vaccination.
Physical review. E, Statistical, nonlinear, and soft matter physics 2007;76(3 Pt 1):031127.
2007: Emily Kajita; Justin T Okano; Erin N Bodine; Scott P Layne; Sally Blower
Modelling an outbreak of an emerging pathogen.
Nature reviews. Microbiology 2007;5(9):700-9.
2007: Catherine M Crespi; William G Cumberland; Anna Wald; Lawrence Corey; Sally Blower
Longitudinal study of herpes simplex virus type 2 infection using viral dynamic modelling.
Sexually transmitted infections 2007;83(5):359-64.
2007: Raffaele Vardavas; Romulus Breban; Sally Blower
Can influenza epidemics be prevented by voluntary vaccination?
PLoS computational biology 2007;3(5):e85.
2007: David P Wilson; Sally Blower
How far will we need to go to reach HIV-infected people in rural South Africa?
BMC medicine 2007;5():16.
2007: Romulus Breban; Raffaele Vardavas; Sally Blower
Theory versus data: how to calculate R0?
PloS one 2007;2(3):e282.
2007: Raffaele Vardavas; Sally Blower
The emergence of HIV transmitted resistance in Botswana: "when will the WHO detection threshold be exceeded?".
PloS one 2007;2(1):e152.
2006: David P Wilson; James Kahn; Sally Blower
Predicting the epidemiological impact of antiretroviral allocation strategies in KwaZulu-Natal: the effect of the urban-rural divide.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(38):14228-33.
2006: Romulus Breban; Ian McGowan; Chad Topaz; Elissa J Schwartz; Peter Anton; Sally Blower
Modeling the potential impact of rectal microbicides to reduce hiv transmission in bathhouses.
Mathematical biosciences and engineering : MBE 2006;3(3):459-66.
2006: Romulus Breban; Sally Blower
Role of parametric resonance in virological failure during HIV treatment interruption therapy.
Lancet 2006;367(9518):1285-9.
2006: David P Wilson; Sally Blower
Rational choices for allocating antiretrovirals in Africa: treatment equity, epidemiological efficiency, and feasibility.
PLoS medicine 2006;3(3):e160.
2005: David P Wilson; Erin N Bodine; Robert J Smith; Sally Blower
Response to Foss et al., 'Care should be taken when promoting microbicide use among sex workers who are able to use condoms consistently'.
AIDS (London, England) 2005;19(17):2044-6.
2005: Romulus Breban; Raffaele Vardavas; Sally Blower
Linking population-level models with growing networks: a class of epidemic models.
Physical review. E, Statistical, nonlinear, and soft matter physics 2005;72(4 Pt 2):046110.
2005: Romulus Breban; Sally Blower
The reinfection threshold does not exist.
Journal of theoretical biology 2005;235(2):151-2.
2005: Sally Blower; Erin N Bodine; Kathie Grovit-Ferbas
Predicting the potential public health impact of disease-modifying HIV vaccines in South Africa: the problem of subtypes.
Current drug targets. Infectious disorders 2005;5(2):179-92.
2005: David P Wilson; Sally Blower
Allocating antiretrovirals in South Africa: using modeling to determine treatment equity.
PLoS medicine 2005;2(6):e155; author reply e186.
2005: Elissa J Schwartz; Sally Blower
Predicting the potential individual- and population-level effects of imperfect herpes simplex virus type 2 vaccines.
The Journal of infectious diseases 2005;191(10):1734-46.
2005: Robert J Smith; Erin N Bodine; David P Wilson; Sally Blower
Evaluating the potential impact of vaginal microbicides to reduce the risk of acquiring HIV in female sex workers.
AIDS (London, England) 2005;19(4):413-21.
2005: Catherine M Crespi; William G Cumberland; Sally Blower
A queueing model for chronic recurrent conditions under panel observation.
Biometrics 2005;61(1):193-8.
2005: David P Wilson; Sally Blower
Designing equitable antiretroviral allocation strategies in resource-constrained countries.
PLoS medicine 2005;2(2):e50.
2004: David P Wilson; Sally Blower
Microbicides: anti-HIV efficacy and ethics.
Science (New York, N.Y.) 2004;306(5703):1890; author reply 1890.
2004: Sally Blower; Anna Wald; Hayley B. Gershengorn; Fei Wang; Larry Corey
Targeting virological core groups: a new paradigm for controlling herpes simplex virus type 2 epidemics.
The Journal of infectious diseases 2004;190(9):1610-7.
2004: Robert J Smith; Sally Blower
Could disease-modifying HIV vaccines cause population-level perversity?
The Lancet infectious diseases 2004;4(10):636-9.
2004: Sally Blower; Tom Chou
Modeling the emergence of the 'hot zones': tuberculosis and the amplification dynamics of drug resistance.
Nature medicine 2004;10(10):1111-6.
2004: Elad Ziv; Charles L Daley; Sally Blower
Potential public health impact of new tuberculosis vaccines.
Emerging infectious diseases 2004;10(9):1529-35.
2004: Sally Blower
Modelling the genital herpes epidemic.
Herpes : the journal of the IHMF 2004;11 Suppl 3():138A-146A.
2003: Sally Blower; Li Ma; Paul Farmer; Serena Koenig
Predicting the impact of antiretrovirals in resource-poor settings: preventing HIV infections whilst controlling drug resistance.
Current drug targets. Infectious disorders 2003;3(4):345-53.
2003: Sally Blower; E J Schwartz; J Mills
Forecasting the future of HIV epidemics: the impact of antiretroviral therapies & imperfect vaccines.
AIDS reviews 2003;5(2):113-25.
2003: Hayley B. Gershengorn; Graham Darby; Sally Blower
Predicting the emergence of drug-resistant HSV-2: new predictions.
BMC infectious diseases 2003;3():1.
2003: Sally Blower; A Nick Aschenbach; Jim O Kahn
Predicting the transmission of drug-resistant HIV: comparing theory with data.
The Lancet infectious diseases 2003;3(1):10-1.
2002: J X Velasco-Hernandez; Hayley B. Gershengorn; Sally Blower
Could widespread use of combination antiretroviral therapy eradicate HIV epidemics?
The Lancet infectious diseases 2002;2(8):487-93.
2002: Sally Blower; C L Daley
Problems and solutions for the Stop TB partnership.
The Lancet infectious diseases 2002;2(6):374-6.
2001: Sally Blower; A N Aschenbach; Hayley B. Gershengorn; J O Kahn
Predicting the unpredictable: transmission of drug-resistant HIV.
Nature medicine 2001;7(9):1016-20.
2001: Sally Blower; K Koelle; Denise E Kirschner; J Mills
Live attenuated HIV vaccines: predicting the tradeoff between efficacy and safety.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(6):3618-23.
2000: T Lietman; Sally Blower
Potential impact of tuberculosis vaccines as epidemic control agents.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;30 Suppl 3():S316-22.
2000: Hayley B. Gershengorn; Sally Blower
Impact of antivirals and emergence of drug resistance: HSV-2 epidemic control.
AIDS patient care and STDs 2000;14(3):133-42.
2000: Sally Blower; Hayley B. Gershengorn; Robert M Grant
A tale of two futures: HIV and antiretroviral therapy in San Francisco.
Science (New York, N.Y.) 2000;287(5453):650-4.
1999: T Lietman; Sally Blower
Tuberculosis vaccines.
Science (New York, N.Y.) 1999;286(5443):1300-1; author reply 1301.
1999: Thomas Lietman; Travis C Porco; C Dawson; Sally Blower
Global elimination of trachoma: how frequently should we administer mass chemotherapy?
Nature medicine 1999;5(5):572-6.
1999: Sally Blower; K Koelle; Thomas Lietman
Antibiotic resistance--to treat...
Nature medicine 1999;5(4):358.
1998: Sally Blower; Travis C Porco; G Darby
Predicting and preventing the emergence of antiviral drug resistance in HSV-2.
Nature medicine 1998;4(6):673-8.
1996: Nelson B Freimer; Sally Blower; Montgomery Slatkin
Pathogens & strain diversity: is sex disruptive?
Nature medicine 1996;2(4):401-3.
1995: Susan K Service; Sally Blower
HIV transmission in sexual networks: an empirical analysis.
Proceedings. Biological sciences / The Royal Society 1995;260(1359):237-44.
1993: Nelson B Freimer; Lodewijk A Sandkuijl; Sally Blower
Incorrect specification of marker allele frequencies: effects on linkage analysis.
American journal of human genetics 1993;52(6):1102-10.